AveragePenny
8月前
$KAYS Kaya Holdings, Inc. Releases Update on Development of Cryptocurrency Subsidiary and Digital Assets Treasury
https://www.accessnewswire.com/newsroom/en/blockchain-and-cryptocurrency/kaya-holdings-inc.-releases-update-on-development-of-cryptocurrency-s-1089695
FT. LAUDERDALE, FL / ACCESS Newswire / October 21, 2025 / Kaya Holdings, Inc. (OTCQB:KAYS) (the "Company" or "KAYS") confirmed that its newly formed cryptocurrency operating subsidiary is conducting ongoing discussions with cryptocurrency foundations and other entities/individuals through its representatives Thomas Gaffney of Conduit Advisors ("Thomas") and the team at Greentree Financial Group ("Greentree") to develop a strategy for becoming a Digital Asset Treasury Company ("DATCO").
Thomas is a seasoned corporate attorney and capital markets strategist with extensive experience in the digital asset sector and has worked on billion-dollar transactions with leading venture firms in the crypto space, including Polychain Capital, VanEck, Frictionless Capital, EV3, and others. The Greentree Team has been involved with a number of recent high profile crypto treasury deals both as an investor and as a financial advisor, providing introductions to and working with registered broker-dealers and investment banking firms that have provided investment capital to companies that have built crypto treasuries.
While the Company has not yet entered into a definitive agreement with any third party, Thomas and the Company's representatives are exploring opportunities with two different groups introduced by Thomas. The Company also plans to engage in dialogue with other cryptocurrency foundations.
KAYS Seeks Potential Cryptocurrency Candidates for Joint Venture Partnership Leading to a Kaya Holdings DATCO
The Company is seeking to develop a joint venture with one or more of the top 200+/- crypto currencies as ranked by market cap. The preferred candidate(s) would most likely be built on the Solana Network (Solana, with its high throughput offers low transaction costs, is ideal for smart contracts, offers optimal strategies for liquidity, lending and leveraged trading, and is user friendly with an emphasis on security), or the Ethereum or Polygon Networks, which both have significant advantages as well. Interested cryptocurrency foundations and other entities and individuals involved with cryptocurrency organizations are urged to reach out to info@kayaholdings.com and open a confidential dialogue.
Why Would Investors Buy a DATCO Instead of the Underlying Cryptocurrency?
One of the structural tailwinds supporting the DATCO model is the regulatory limitation on direct crypto exposure faced by large institutional allocators. As economist Lyn Alden notes in "The Rise of Bitcoin Stocks and Bonds," trillions of dollars in global capital are managed under mandates that prohibit direct ownership of digital assets but permit investments in publicly listed equities. For these investors (pensions, sovereign wealth funds, endowments), DATCOs offer compliant access to crypto exposure, and their share prices often reflect this scarcity. Instead of just buying the crypto already on the balance sheet, investors are buying the regulatory arbitrage and capital formation flywheel these companies represent.
Joint Venture and the Path Forward
When and if a a joint venture is established and the Company begins to bring yield generating digital assets onto its balance sheet, the goal is for the Company to work towards an uplisting to the Nasdaq Stock Market LLC. Nasdaq is a much more mature and sophisticated trading market with access to a large number of potential investors which could potentially assist the Company in fully implementing its Digital Asset Treasury strategy in a relatively short period of time.
The Company confirms it has entered into both debt reduction and debt conversion agreements with its debt holders to convert over 90% of its existing debt into equity, so as to provide a much cleaner balance sheet for the potential joint venture and restructuring to a DATCO.
Additionally, the Company has begun to reach out to different entities in Grand Cayman, a leading global offshore financial center, to help build out its planned cryptocurrency operations. In recent years, Grand Cayman and the Cayman Islands have emerged as a Cryptocurrency and Digital Assets Financial Center, and the Company is working to leverage its contacts there for both potential investment in the cryptocurrency subsidiary and access to cryptocurrency trading and service platforms.
AveragePenny
10月前
$KAYS Kaya Holdings, Inc. Engages Greentree Financial Group and Conduit Advisors to Assist with Development of Cryptocurrency Subsidiary and Implementation of Digital Assets Treasury Strategy
https://www.accessnewswire.com/newsroom/en/agriculture/kaya-holdings-inc.-engages-greentree-financial-group-and-conduit-advisors-to-assist-wit-1074519
FT. LAUDERDALE, FL / ACCESS Newswire / September 17, 2025 / Kaya Holdings, Inc. (OTCQB:KAYS) (the "Company" or "KAYS") announced today that the Company has engaged Greentree Financial Group, Inc. ("Greentree") and Conduit Advisors, LLC ("Conduit") to assist the Company with the development of a new cryptocurrency operating subsidiary through which it will seek to develop, launch and implement of a Digital Assets Treasury (DAT) strategy and related cryptocurrency operations.
Greentree has been involved with a number of recent high profile crypto treasury deals both as an investor and as a financial advisor, providing introductions to and working with registered broker-dealers and investment banking firms that have provided investment capital to companies that have built crypto treasuries.
Thomas Gaffney, the founder of Conduit, has been involved in recent crypto treasury initiatives as a corporate attorney and capital markets strategist. Conduit has extensive experience in the digital asset sector, providing introductions to and securing agreements with various cryptocurrency groups for public company clients.
KAYS and its advisors are currently reviewing potential plans to enter into the cryptocurrency industry through various channels such as setting up licensed cryptocurrency custody and trading services in the United States, Grand Cayman and other jurisdictions, working with specific crypto foundations, for-profit companies and Decentralized Autonomous Organizations to capitalize on opportunities available with different cryptocurrencies and blockchain technologies, as well as participating in the launch of new crypto coins and the associated networks.
KAYS intends to leverage its public company operating status and historical connections to Grand Cayman, a leading global offshore financial center, to help build out its planned cryptocurrency operations. In recent years, Grand Cayman and the Cayman Islands have emerged as a Cryptocurrency and Digital Assets Financial Center, serving as a popular domicile for crypto-focused and tokenized funds, SPACs, and other entities due to its clear regulatory framework, experienced service providers, and established position as a global financial hub. The jurisdiction has developed specific legislation, such as the Virtual Asset (Service Providers) Act (VASP Act), to address the crypto industry.
The ability of KAYS to develop, launch and implement its proposed Digital Assets Strategy and related cryptocurrency operations is dependent on the various factors, including, with the assistance of Greentree and Conduit, satisfying or converting the Company's existing indebtedness into equity and otherwise restructuring the Company's capital to support a Digital Assets Treasure strategy, identifying and negotiating the acquisition of digital assets and financing the acquisition and implementation of the strategy. Accordingly, there can be no assurance that KAYS can successfully develop, launch and implement its proposed cryptocurrency operations.
AveragePenny
1年前
$KAYS Kaya Holdings, Inc. (OTCQB:KAYS): The Sacred Mushroom, Oregon's Premier Psilocybin Treatment Center Introduces "Synergy by Design" Journey Customization Program
https://www.accessnewswire.com/newsroom/en/agriculture/kaya-holdings-inc-otcqbkays-the-sacred-mushroom-oregons-premier-psilocybin-treatment-center-introduces-synergy-by-design-journey-customization-program-969432
PORTLAND, OR / ACCESS Newswire / January 16, 2025 / Kaya Holdings, Inc. (OTCQB:KAYS) and The Sacred Mushroom™ ("TSM"), Portland's one-of-a-kind psilocybin treatment center today announced the launch of "Synergy by Design," a revolutionary program that empowers individuals to curate deeply personal and transformative psychedelic journeys. By combining intention, sensory customization, and meaningful activities, this program is designed to ensure that every participant's experience reflects their unique needs, preferences, and goals.
The Sacred Mushroom™, at 11,000 sq. ft., has been purposely curated to provide every TSM guest with the full transformative potential of the psychedelic journey. Guests can access their perfect setting through TSM's proprietary "Synergy by Design" and interact with journey-enhancing activities such as art expression, body movement, and journaling.
What is Synergy by Design?
Synergy by Design is a framework rooted in personalization and empowerment, offering participants the tools to craft their own transformative psilocybin journeys. Each step invites individuals to align their surroundings, activities, and intentions to create meaningful experiences.
With Synergy by Design, The Sacred Mushroom™ guest can select their surroundings, creating a sensory environment that aligns with their goals by customizing:
Space: Guests choose from serene settings like a quiet nook, lush indoor garden, or private room for maximum comfort and inspiration.
Sounds: Music or ambient sounds, with options including live musicians, curated playlists, or nature's calming white noise.
Scents: Essential oils, herbal infusions, or natural room fragrances to complete the sensory palette.
Synergy By Design further provides activities for guests to tailor to enhance their experience:
Creative Expression: Painting, journaling, crafting, clay sculpturing, kinetic sand, and musical instruments provided.
Mind-Body Connection: An area reserved for yoga, meditation, or body movement exercises.
"At The Sacred Mushroom™, we believe every individual deserves a journey that reflects their unique spirit and aspirations," said Bryan Arnold, Chief Facilitator at The Sacred Mushroom™. Synergy by Design's objective is to ensure that every detail is curated to support our guest."
KAYS CEO Statement
"This unique program is possible because of the size of our facility and our commitment to transform the space into the absolutely ideal psilocybin treatment setting," stated KAYS' CEO Craig Frank. "Synergy By Design is the next step toward achieving the experience we seek to provide, enabling the guest to construct their own visual, auditory and olfactory inputs. It is the ultimate in crafting a personal psilocybin journey. This program is yet another example of how The Sacred Mushroom™ is pioneering psychedelics and setting the stage for change in the $82.47 billion mental healthcare sector".
AveragePenny
2年前
$KAYS Kaya Holdings, Inc. and the Sacred Mushroom(TM) Psilocybin Treatment Facility Announce Inaugural Open House and New Series of Low-Dose Psilocybin Sessions
https://www.accesswire.com/958899/kaya-holdings-inc-and-the-sacred-mushroom-tm-psilocybin-treatment-facility-announce-inaugural-open-house-and-new-series-of-low-dose-psilocybin-sessions
PORTLAND, OR / ACCESSWIRE / December 23, 2024 / Kaya Holdings, Inc. (OTCQB:KAYS) and The Sacred MushroomTM, Portland's one-of-a-kind psilocybin treatment center, are excited to announce their first Open House event to be held on Friday, December 27, 2024, from 5:00 PM to 8:00 PM.
This event offers the community a unique opportunity to explore our state-of-the-art facility, meet the team, and learn about the transformative potential of psilocybin-assisted therapies.
To get tickets to the event please access the following link:
https://www.eventbrite.com/e/the-sacred-mushroom-open-house-tickets-1116887333079?aff=oddtdtcreator
During the Open House, attendees will have the chance to tour private treatment rooms, experience the indoor garden, and discover the many activities offered, including art and musical expression, body movement, and mindfulness practices. The Sacred MushroomTM emphasizes the importance of a curated setting, providing a safe and enriching environment for personal growth and healing. Whether you're curious, exploring options for yourself or a loved one, or simply seeking a moment of relaxation, this open house is a perfect opportunity to unwind, connect, and explore what we offer.
As part of its mission to foster deeper connections and healing through creativity and introspection, The Sacred MushroomTM is also thrilled to announce the launch of its "Community, Culture, and a Touch of Psilocybin" series. These group sessions, centered around low-dose psilocybin experiences, will celebrate the works of respected musicians, authors, poets, and visual artists. Each session is designed to blend artistic appreciation with guided introspection, creating a space for participants to explore while building community bonds.
Bryan Arnold, Chief Facilitator of The Sacred MushroomTM, shared: "We are committed to making psilocybin therapy accessible and impactful. With our new series, we aim to merge the transformative power of psilocybin with the inspiration of art, music, and literature to foster growth, healing, and connection."
Attendees of the Open House will receive exclusive details about upcoming sessions in the series and have the opportunity to reserve spots at a special introductory rate. The public (over age 21) is invited to visit The Sacred MushroomTM at 321 SW Glisan Street in Old Towne Portland on December 27 to experience The Sacred Mushroom'sTM revolutionary approach to psilocybin therapy and learn more about how art and culture can intersect with personal transformation.
Titled "Is Psilocybin Right for You?", the e-book details the therapeutic benefits psilocybin can offer to people with mental health concerns or those simply curious. To access a copy of our e-book "Is Psilocybin Right for You?", please click on the above image or go to:
https://thesacredmushroompdx.com/e-book-library/
Once you have accessed the site you can read the book online or download it to be read later offline.
Topics addressed in the book include: What is Psilocybin, How Does Psilocybin Affect the Brain, History of Psilocybin, Is Psilocybin Treatment Right for You, Psilocybin & Personal Growth, Psilocybin & Happiness, Psilocybin & Inner Peace, Psilocybin & Creativity, Psilocybin & Post Traumatic Stress Disorder, Psilocybin & Depression, Psilocybin & Obsessive-Compulsive Disorder, Psilocybin & Sexual Trauma, Psilocybin & Anxiety, Psilocybin & Substance/Alcohol Abuse & Addiction, Psilocybin & Eating Disorders, Psilocybin & Alzheimer's Disease, Psilocybin & End of Life Anxiety, Psilocybin & Cluster Headaches, Understanding Dosing, Risks, The Importance of Integration, and Exploring the Power of Psilocybin at The Sacred MushroomTM.
About The Sacred MushroomTM (https://thesacredmushroompdx.com)
The Sacred Mushroom™ is a legally licensed psilocybin treatment center authorized by the State of Oregon to administer psilocybin treatments within the regulations set forth by the Oregon Health Authority.
AveragePenny
2年前
$KAYS The Sacred Mushroom(TM) Psilocybin Center Operated by Kaya Holdings, Inc. (OTCQB:KAYS) Releases First E-Book
https://www.accesswire.com/926572/the-sacred-mushroomtm-psilocybin-center-operated-by-kaya-holdings-inc-otcqbkays-releases-first-e-book
"Is Psilocybin Right for You" is the first in a planned series of helpful e-books about psilocybin.
FT. LAUDERDALE, FL / ACCESSWIRE / October 2, 2024 / The Sacred Mushroom™ ("TSM"), an emerging leader in the delivery of psilocybin experiences at its Portland, Oregon facility, announced the release of its first in a series of planned e-books on psilocybin and related issues.
Titled "Is Psilocybin Right for You?", the e-book details the therapeutic benefits psilocybin can offer to people with mental health concerns or those simply curious.
To access a copy of our e-book "Is Psilocybin Right for You?", please click on the image above or go to https://thesacredmushroompdx.com/is-psilocybin-right-for-you-tsm/. Once you have accessed the site you can read the book online or download it to be read later offline.
Topics addressed in the book include: What is Psilocybin, How Does Psilocybin Affect the Brain, History of Psilocybin, Is Psilocybin Treatment Right for You, Psilocybin & Personal Growth, Psilocybin & Happiness, Psilocybin & Inner Peace, Psilocybin & Creativity, Psilocybin & Post Traumatic Stress Disorder, Psilocybin & Depression, Psilocybin & Obsessive-Compulsive Disorder, Psilocybin & Sexual Trauma, Psilocybin & Anxiety, Psilocybin & Substance/Alcohol Abuse & Addiction, Psilocybin & Eating Disorders, Psilocybin & Alzheimer's Disease, Psilocybin & End of Life Anxiety, Psilocybin & Cluster Headaches, Understanding Dosing, Risks, The Importance of Integration, and Exploring the Power of Psilocybin at The Sacred Mushroom™.
For more information or to make an appointment for psilocybin services at The Sacred Mushroom™, please go to https://tsmpdx.com or send an email to info@tsmpdx.com
CEO Statement
KAYS CEO Craig Frank comments on the release of "Is Psilocybin Right for You?", "This e-book, and the others we have planned in the series, bring to a broader audience the information they need to make an informed choice with regard to newly available psilocybin journeys. We welcome everyone seeking to experience the transformative journeys psilocybin can bring. We hope this e-book, and the others that follow, will add to the conversation'
AveragePenny
2年前
$KAYS Kaya Holdings, Inc. (OTCQB:KAYS) Criticizes FDA Rejection of MDMA Therapy for PTSD, Proposes Psilocybin as Alternative Treatment
https://www.accesswire.com/900068/kaya-holdings-inc-otcqbkays-criticizes-fda-rejection-of-mdma-therapy-for-ptsd-proposes-psilocybin-as-alternative-treatment
FT. LAUDERDALE, FL / ACCESSWIRE / August 13, 2024 / Kaya Holdings, Inc., ("KAYS" or the "Company") (OTCQB:KAYS), a "mind care" company with operations in the emerging psilocybin treatment sector and in medical/recreational cannabis, criticized the FDA ruling rejecting MDMA (Ecstasy) therapy as a treatment for PTSD. KAYS, which provides psilocybin treatment services at its Portland, Oregon facility, The Sacred Mushroom ™ proposes consideration of psilocybin therapy as an alternative treatment for PTSD and welcomes anyone seeking psilocybin treatment for PTSD, as permitted by Oregon law.
The Sacred Mushroom ™
The Sacred Mushroom™ is a legally licensed psilocybin treatment center authorized by the State of Oregon to administer psilocybin treatments within the regulations set forth by the Oregon Health Authority ("OHA").
The Sacred Mushroom™, at 11,000 sq. ft., has been purposely designed to provide every TSM guest with the full transformative potential of the psychedelic journey offered by psilocybin. Guests can access their perfect setting through TSM's proprietary "Synergy by Design" and interact with journey-enhancing activities such as art expression, body movement, and journaling.
CEO Statement
Craig Frank, KAYS' CEO responded to the FDA's rejection of MDMA decision, saying, "We are deeply sorry the FDA has decided against MDMA use for the treatment of PTSD and regret the impact this may have on developing a PTSD treatment needed by so many, including numerous military veterans. It is our view that psilocybin, whose use has been authorized by the state of Oregon, offers a potential alternative for treating PTSD, and we invite researchers, organizations and individuals previously focused on using MDMA as a treatment for PTSD, to consider psilocybin treatment and view The Sacred Mushroom™ as a safe, legal space where psilocybin may be administered in a comfortable, welcoming setting."
Psilocybin as a potential alternative to MDMA as a treatment for PTSD
Emerging research has shown that psilocybin can have lasting therapeutic effects after just one or two sessions. A study published in the Journal of Psychopharmacology found that psilocybin-assisted therapy reduced symptoms of depression and anxiety in patients with life-threatening cancer, which often includes PTSD-like symptoms. Another study in Nature Medicine demonstrated that psilocybin-assisted therapy led to significant and sustained improvements in PTSD symptoms in a cohort of military veterans. The effects were particularly noted in the reduction of avoidance behaviors and hyperarousal, which are key components of PTSD.
These published studies, along with additional studies at Kings College, London and John Hopkins University in Baltimore have allowed a comparison of MDMA and psilocybin on matters of efficacy and duration, side effects, and safety profiles. A summary of the comparison reveals:
The time of a psilocybin experience is typically longer than the MDMA experience, and this more prolonged session could provide more time for psychological processing and integration of insights gained during the experience.
While psilocybin typically produces a more introspective and insightful experience with visual and auditory hallucinations, MDMA typically enhances one's feelings of empathy and connection to others without hallucinations. The introspective nature of the psilocybin experience may facilitate deeper psychological integration compared to the shorter-lasting effects of MDMA.
The side effects of psilocybin generally milder than those of MDMA, which include changes in heart rate, dehydration, jaw clenching, nausea, anxiety and agitation, sweating and chills.
Psilocybin has a preferred safety profile with regard to potential for abuse and risk of developing a dependency, compared to MDMA.
abracky
4年前
Notification That Quarterly Report Will Be Submitted Late (nt 10-q)
Source: Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
SEC FILE NUMBER 333-177-532
CUSIP NUMBER 0215X109
(Check One): [ ] Form 10-K [_] Form 20-F [X] Form 10-Q [_] Form 10-D [_] Form N-SAR
For Period Ended: September 30, 2022
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
.PART I -- REGISTRANT INFORMATIONKaya Holdings, IncFull Name of RegistrantFormer Name if Applicable
915 Middle River Drive Suite 316
Address of Principal Executive Office (Street and Number)Fort Lauderdale, FL 33304City, State and Zip Code
PART II -- RULES 12B-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
[x](a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense;(b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K or Form N-SAR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and(c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
PART III--NARRATIVE
State below in reasonable detail why forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, or the transition report or portion thereof, could not be filed within the prescribed time period.
Registrant requires additional time to complete the preparation of its financial statements for the quarter ended September 30, 2022, have them properly certified by the executive officers and have them reviewed by its independent auditors. The Registrant will file the Form 10-Q by the fifth calendar day following the required filing date, as prescribed in Rule 12b-25.
PART IV--OTHER INFORMATION
(1)Name and telephone number of person to contact in regard to this notificationCraig Frank561210-5784(Name)(Area Code)(Telephone Number)
(2)Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s).
[x] Yes [_] No
(3)Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof?
[_] Yes [x] No
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
Kaya Holdings, Inc.(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
DateNovember 14, 2022By/s/ Craig Frank
INSTRUCTION: The form may be signed by an executive officer or the registrant or by any other duly authorized representative. The name and title of the person signing the form shall be typed or printed beneath the signature. If the statement is signed on behalf of the registrant by an authorized representative (other than an executive officer), evidence of the representative’s authority to sign on behalf of the registrant shall be filed with the form.
Hot Features
プレミアム
登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
resx18
2年前
メールアドレスで登録
